Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

249 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Therapeutic results and changes in prognosis in patients with multiple myeloma in central and northern Moravia over the past 40 years].
Scudla V, Bacovský J, Indrák K, Kod'ousková V, Vytrasová M, Faber E, Papajík T, Vavrdová V, Adam Z, Hájek R, Farbiaková V, Srovnalík K, Novosadová L, Vránová M, Micaníková M, Sumná E, Kuca B, Slezar J, Heincová V, Gumulec J, Zivná J, Schlemmer P, Lautnerová E, Lasota Z, Kubecková M, Krajsová I, Růzicka M, Cíhal K, Martínek A, Cernosek B, Doubravský J, Papajík J, Prodĕlal P. Scudla V, et al. Among authors: faber e. Vnitr Lek. 2002 Aug;48(8):707-17. Vnitr Lek. 2002. PMID: 12425200 Czech.
Individually determined dosing of filgrastim after autologous peripheral stem cell transplantation in patients with malignant lymphoma--results of a prospective multicentre controlled trial.
Faber E, Pytlík R, Slabý J, Zapletalová J, Kozák T, Raida L, Papajík T, Zikesová E, Maresová I, Hamouzová M, Indrák K, Trnený M. Faber E, et al. Eur J Haematol. 2006 Dec;77(6):493-500. doi: 10.1111/j.1600-0609.2006.00741.x. Epub 2006 Oct 17. Eur J Haematol. 2006. PMID: 17042769 Clinical Trial.
Prolonged survival of patients with peripheral T-cell lymphoma after first-line intensive sequential chemotherapy with autologous stem cell transplantation.
Prochazka V, Faber E, Raida L, Vondrakova J, Kucerova L, Jarosova M, Indrak K, Papajik T. Prochazka V, et al. Among authors: faber e. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2009 Mar;153(1):63-6. doi: 10.5507/bp.2009.011. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2009. PMID: 19365529 Free article.
Rituximab does not adversely affect the stem cell mobilization and engraftment after high-dose therapy and autologous transplantation in patients with diffuse large B-cell lymphoma in first complete or partial remission.
Papajik T, Pikalova Z, Raida L, Skoumalova I, Vondrakova J, Faber E, Prochazka V, Kubova Z, Kucerova L, Pavlik T, Dusek L, Indrak K. Papajik T, et al. Among authors: faber e. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2009 Sep;153(3):211-4. doi: 10.5507/bp.2009.035. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2009. PMID: 19851434 Free article.
Long-term outcome of patients with peripheral T-cell lymphoma treated with first-line intensive chemotherapy followed by autologous stem cell transplantation.
Prochazka V, Faber E, Raida L, Papajik T, Vondrakova J, Rusinakova Z, Kucerova L, Myslivecek M, Indrak K. Prochazka V, et al. Among authors: faber e. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2011 Mar;155(1):63-9. doi: 10.5507/bp.2011.009. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2011. PMID: 21475380 Free article.
Treatment of consecutive patients with chronic myeloid leukaemia in the cooperating centres from the Czech Republic and the whole of Slovakia after 2000--a report from the population-based CAMELIA Registry.
Faber E, Mužík J, Koza V, Demečková E, Voglová J, Demitrovičová L, Chudej J, Markuljak I, Cmunt E, Kozák T, Tóthová E, Jarošová M, Dušek L, Indrák K. Faber E, et al. Eur J Haematol. 2011 Aug;87(2):157-68. doi: 10.1111/j.1600-0609.2011.01637.x. Eur J Haematol. 2011. PMID: 21535160
249 results